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Abstract
Background: Antibiotics are essential to treat for many childhood bacterial infections; however inappropriate
antibiotic use contributes to antimicrobial resistance. For childhood diarrhea, empiric antibiotic use is
recommended for dysentery (bloody diarrhea) for which first-line therapy is ciprofloxacin. We assessed
inappropriate antibiotic prescription for childhood diarrhea in two primary healthcare facilities in Kenya.
Methods: We analyzed data from the Kenya Population Based Infectious Disease Surveillance system in Asembo
(rural, malaria-endemic) and Kibera (urban slum, non-malaria-endemic). We examined records of children aged 2–
59 months with diarrhea (≥3 loose stools in 24 h) presenting for care from August 21, 2009 to May 3, 2016,
excluding visits with non-diarrheal indications for antibiotics. We examined the frequency of antibiotic over-
prescription (antibiotic prescription for non-dysentery), under-prescription (no antibiotic prescription for dysentery),
and inappropriate antibiotic selection (non-recommended antibiotic). We examined factors associated with over-
prescription and under-prescription using multivariate logistic regression with generalized estimating equations.
Results: Of 2808 clinic visits with diarrhea in Asembo, 2685 (95.6%) were non-dysentery visits and antibiotic over-
prescription occurred in 52.5%. Of 4697 clinic visits with diarrhea in Kibera, 4518 (96.2%) were non-dysentery and
antibiotic over-prescription occurred in 20.0%. Antibiotic under-prescription was noted in 26.8 and 73.7% of
dysentery cases in Asembo and Kibera, respectively. Ciprofloxacin was used for 11% of dysentery visits in Asembo
and 0% in Kibera. Factors associated with over- and under-prescription varied by site. In Asembo a discharge
diagnosis of gastroenteritis was associated with over-prescription (adjusted odds ratio [aOR]:8.23, 95% confidence
interval [95%CI]: 3.68–18.4), while malaria diagnosis was negatively associated with antibiotic over-prescription (aOR
0.37, 95%CI: 0.25–0.54) but positively associated with antibiotic under-prescription (aOR: 1.82, 95%CI: 1.05–3.13). In
Kibera, over-prescription was more common among visits with concurrent signs of respiratory infection (difficulty
breathing; aOR: 3.97, 95%CI: 1.28–12.30, cough: aOR: 1.42, 95%CI: 1.06–1.90) and less common among children aged
< 1 year (aOR: 0.82, 95%CI: 0.71–0.94).
Conclusions: Inappropriate antibiotic prescription was common in childhood diarrhea management and efforts are
needed to promote rational antibiotic use. Interventions to improve antibiotic use for diarrhea should consider the
influence of malaria diagnosis on clinical decision-making and address both over-prescription, under-prescription,
and inappropriate antibiotic selection.
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Background
Inappropriate antibiotic use, which includes prescribing
unnecessary antibiotics, prescribing incorrect antibiotics,
and not prescribing antibiotics when needed, is a major
public health problem [1]. Overuse and misuse of antibi-
otics adds to the cost of treatment, risks adverse
reactions and enhances the development of resistant
pathogens [2]. According to a recent report on global anti-
microbial resistance by the World Health Organization
(WHO), antimicrobial resistance among pathogens respon-
sible for common infections is alarmingly high [3]. In order
to combat pressing public health concerns of antimicrobial
resistance, a global action plan was adopted by the World
Health Assembly in 2015 [4]. Increasing adherence to
standard treatment guidelines has been highlighted as a
core action to promote rational use of antibiotics [5, 6].
Antibiotics are frequently prescribed for common
clinical syndromes, yet are not recommended for the
majority of diarrheal episodes. For childhood diarrhea in
resource-poor settings, WHO guidelines for the Inte-
grated Management of Childhood Illness (IMCI) recom-
mend empirical use of antibiotics only for dysentery, or
bloody diarrhea [7], including high HIV prevalence
settings [8]. For dysentery, antibiotics are intended to
treat shigellosis which causes the most episodes of
bloody diarrhea in children [9, 10], and ciprofloxacin is
the recommended first-line agent. The recommended
management of watery childhood diarrhea is oral rehy-
dration and zinc [9] as they are most commonly caused
by viral infections.
Diarrheal disease remains a major cause of morbidity
and mortality among children under 5 years in Kenya
[11], and Shigella bacteria has been frequently isolated
in patients with dysentery, 66% for toddlers and 78% for
children [12]. The Ministry of Health’s recommended
management of diarrhea in Kenya is consistent with the
WHO IMCI guidelines [13]. Although antibiotic overuse
has been reported to be common in Kenya [14], little is
known about specific antibiotic prescription practices
for the management of childhood diarrhea in primary
care facilities and their driving factors. In the current
analysis, we aimed to measure the prevalence of
inappropriate antibiotic prescription for childhood
diarrhea case management and to determine factors
associated with antibiotic over-prescription and under-
prescription in one urban and one rural primary care
facility in Kenya.
Methods
Study setting and data collection
We used data from the ongoing Population-Based Infec-
tious Disease Surveillance (PBIDS) platform of the
Kenya Medical Research Institute (KEMRI) and U.S.
Centers for Disease Control and Prevention (CDC) in
Kenya, described elsewhere [15]. In brief, approximately
25,000 individuals are under surveillance in each of two
sites; a rural, sparsely populated, malaria-endemic setting
in western Kenya (Asembo) and an urban, non-malaria
endemic, densely populated, informal settlement in
Nairobi, Kenya (Kibera). PBIDS participants receive free
medical care for acute illness, including medications, at
centrally located surveillance clinics. In Asembo all
PBIDS households are within a ~ 5 km radius of the St.
Elizabeth Lwak Mission Hospital, which offers predom-
inantly outpatient services but also has a small inpatient
ward. In Kibera all PBIDS households are within a ~ 1
km radius of the Tabitha clinic, which offers outpatient
services only.
At the surveillance clinics, a structured questionnaire
is administered by trained study staff to collect informa-
tion on medical history including use of prophylactic
cotrimoxazole and antiretroviral medication, and re-
ported clinical symptoms, followed by detailed history
taking and physical examinations performed by clinical
officers. All data are captured in an electronic medical
record system, including clinical diagnoses, any medica-
tions prescribed and if the patient illness met the case
definitions of one of the four syndromes under surveil-
lance (acute respiratory infection, acute lower respiratory
infection, diarrhea, and acute febrile illness) [15]. Pa-
tients meeting the case definition for diarrhea (3 or
more loose stools in the prior 24 h), are asked to provide
a whole stool sample; however, stool testing results are
not available immediately to guide clinical management
during the clinic visit at which they are collected due to
processing times. In addition, both facilities conduct
on-site microscopic examination of stool for ova and
parasites, and peripheral blood smear for malaria at the
discretion of the clinician but not systematically for sur-
veillance purposes.
Inclusion, exclusion, and outcome criteria
We identified surveillance records of clinic visits of
PBIDS participants aged 2–59 months presenting with
diarrhea from August 21, 2009 to May 3, 2016. We
then excluded records in which there was a non-diar-
rheal indication for antibiotics per IMCI guidelines,
including those meeting criteria for possible serious
bacterial infection, severe pneumonia or very severe
disease, pneumonia, very severe febrile disease, and
acute ear infection [7]. Although IMCI also
recommends antibiotics for mastoiditis and severe
complicated measles, the surveillance data did not
contain the necessary variables to identify such cases
based on clinical criteria; however visits with a
discharge diagnosis of either of these were excluded.
We also excluded records with a discharge diagnosis
of meningitis, pneumonia, acute otitis media, or
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bacteremia, regardless of whether IMCI criteria for
antibiotics were met. Since we were interested in the
use of antibiotics for diarrhea based on clinical signs
and symptoms, we also excluded records with a dis-
charge diagnosis of amoebiasis or giardiasis, since mi-
croscopy results may have prompted prescription of
antibiotics for those cases. Clinic visits with missing
variables were excluded as we weren’t able to assess
antibiotic indication per IMCI guidelines.
The remaining diarrheal cases were categorized into
dysentery and non-dysentery, based on parental report
and/or clinician observation of blood in the stool. We
reviewed treatment data for any antibiotics prescribed
during the clinical visit encounter. Antibiotic over-pre-
scription was defined as an antibiotic prescription for
non-dysentery cases and under-prescription as no anti-
biotic prescription for dysentery cases. Inappropriate
antibiotic selection was defined as prescription of
non-recommended antibiotic for dysentery cases by the
guidelines [16, 17].
Statistical analysis
Statistical analyses were performed separately for each site
due to heterogeneity between the two settings. Comparison
between groups were performed by Pearson chi-squared or
Fisher’s exact test for categorical variables and Student’s
t-test for continuous variables. Multivariate logistic regres-
sion was used to identify factors associated with antibiotic
over-prescription and under-prescription for each site. For
multivariate analyses, variables were initially selected using
a cut-off p-value of 0.2 based on univariate analyses and
final multivariate models were constructed using the least
absolute shrinkage and selection operator regression [18].
Interaction terms were explored for any statistical signifi-
cance and multiple stopping criteria were used to identify
the best fit model. To account for clustering of antibiotic
prescription tendency by clinical officers, we also adjusted
for the standard errors using generalized estimating equa-
tions [19]. All statistical analyses were performed in SAS
Software version 9.3 (SAS Institute, Inc., Cary, NC). All
tests were two-sided and used the 5% level of significance.
Fig. 1 Classification of diarrheal children under five by Integrated Management of Childhood Illness guidelines in Kenya Population Based
Infectious Disease Surveillance, August 21, 2009–May 3, 2016
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Results
Of 78,602 clinic visits of children aged 2–59months in
the study period, 11,159 (14.2%) were clinic visits of pa-
tients with diarrhea (Fig. 1). We excluded 3654 (32.7%)
clinic visits with a non-diarrheal indication for antibi-
otics as defined on the Additional file 1:Table S1, and
284 (2.5%) with a diagnosis of giardiasis or amoebiasis,
leaving 7505 (67.3%) visits for final analyses, including
2808 and 4697 visits for Asembo and Kibera respect-
ively. In Asembo, 2685 (95.6%) visits were non-dysentery
and antibiotic over-prescription prevalence was 52.5%.
Of 123 (4.4%) dysentery visits in Asembo, antibiotic
under-prescription prevalence was 26.8%. In Kibera,
4518 (96.2%) visits were non-dysentery and antibiotic
over-prescription prevalence was 20.0%. Of 179 (3.8%)
dysentery visits in Kibera, antibiotic under-prescription
prevalence was 73.7%. During the study period, Asembo
had 41 clinical officers who treated 46 diarrheal children
on average (range 1–397) and Kibera had 37 clinical
officers who treated 127 diarrheal children on average
(range 1–1199).
Antibiotic over-prescription was more common in
Asembo than Kibera (52.5% vs. 20.0%, p < 0.01) and fac-
tors associated with over-prescription varied between the
sites (Tables 1, 2). In Asembo, antibiotic over-prescription
was positively associated with a discharge diagnosis of
gastroenteritis [OR: 8.23 95% CI: 3.68–18.40] but
negatively associated with a diagnosis of malaria [OR: 0.37
95%CI: 0.25–0.54] and concurrent oral rehydration
solution (ORS) treatment [OR: 0.49 95%CI: 0.33–0.71].
We found a significant interaction between gastroenteritis
diagnosis and concurrent ORS treatment in Asembo
(Additional file 1: Table S2). The ORS treatment prescrip-
tion with documented gastroenteritis diagnosis was
negatively associated with antibiotic over-prescription
[OR: 0.35 95% CI: 0.22–0.54] while ORS treatment with-
out documented gastroenteritis diagnosis was not associ-
ated with antibiotic over-prescription. In Kibera, antibiotic
over-prescription was positively associated with prior anti-
biotic treatment at the surveillance facility within the last
14 days, measured or reported fever, cough, difficulty
breathing, and abnormal auscultation findings of crackles
or rales. Association with gastroenteritis diagnosis or ORS
treatment was not found in Kibera. Age less than 1 year
was negatively associated with antibiotic over-prescription
[OR: 0.82 95%CI: 0.71–0.94].
The proportion of visits with dysentery was similar across
sites (4.4% is Asembo and vs. 3.8% in Kibera, p = 0.22), but
antibiotic under-prescription was more common in Kibera
than Asembo (73.7% vs. 26.8%, p < 0.01) (Tables 3, 4). In
Asembo, under-prescription was associated with vomiting
[OR: 4.36 95%CI: 1.98–9.57] and a discharge diagnosis of
malaria [OR: 1.82 95%CI: 1.05–3.13]. In Kibera,
under-prescription was positively associated with age less
than 1 year [OR: 4.76 95%CI: 1.46–15.5], and negatively as-
sociated with a discharge diagnosis of dysentery [OR: 0.10
95%CI: 0.03–0.34].
For dysentery visits, the most common antibiotics pre-
scribed in both sites were erythromycin, metronidazole,
and nalidixic acid (Fig. 2). Cotrimoxazole was commonly
prescribed in Asembo for dysentery visits, but not used
in Kibera. Ciprofloxacin, the recommended agent, was
prescribed in 11% of dysentery visits in Asembo and 0%
in Kibera. For diarrheal non-dysentery visits, the
commonly prescribed antibiotics were erythromycin and
metronidazole in Kibera and cotrimoxazole, erythro-
mycin and metronidazole in Asembo (Fig. 3).
Discussion
Inappropriate antibiotic prescription for childhood diar-
rhea management was common in both rural and urban
sites in Kenya. Overall, 34.2% of diarrhea visits to health
facilities had either over-prescription, under-prescription,
or inappropriate choice of antibiotics. Antibiotic
over-prescription was observed more frequently in the
rural, malaria-endemic area while under-prescription was
more predominant in the urban, densely populated, slum
area. We found little overlap in the factors associated with
antibiotic over-prescription and under-prescription
between two study sites. Our findings indicate that
despite presence of national and international guide-
lines, the magnitude of antibiotic over-prescription
and under-prescription, and the factors that drive
them, can vary greatly between facilities.
More than 95% of diarrhea clinic visits did not warrant
antibiotics. Yet we found that antibiotics were inappro-
priately prescribed for 2 to 5 of every 10 cases of
non-dysentery diarrhea. These results are consistent
with other studies that have reported frequent antibiotic
over-prescription for diarrhea in resource-limited out-
patient settings. A cross-sectional study assessing anti-
biotic prescribing practice for the management of
diarrhea in Tanzania reported 54.4% of children with
acute watery diarrhea were prescribed with antibiotics
inappropriately [20]. Similar studies in India and
Thailand reported antibiotic overuse of 71 and 55.2%
respectively [21, 22]. We found over-prescription to be
more common in the rural site than an urban informal
settlement, which is consistent with a study of antibiotic
consumption in Heilongjiang Province, China [23].
Factors such as knowledge and attitude of caregiver or
distance needed to travel for clinic visit might have in-
fluenced the differences between rural and urban sites.
In contrast, a study conducted in Ethiopia found no dif-
ference in antibiotics overuse between rural and urban
sites [24]. Despite differences between the rural and
urban settings in our study, the overall frequency of in-
appropriate use for diarrhea is alarming, and is likely
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contributing to the emergence of antimicrobial resist-
ance in Kenya [25, 26].
Factors associated with antibiotic over-prescription
varied by site. In Asembo, diarrheal children were more
likely to be prescribed with antibiotic when they were
clinically diagnosed with gastroenteritis, suggesting that
clinicians perceive acute diarrheal illness as an indication
for antibiotics, despite IMCI and national guidelines rec-
ommend antibiotics only for bloody diarrhea. Further-
more, in Kibera, fever, cough, difficulty breathing and
abnormal respiratory exam findings were associated with
antibiotic over-prescription. This constellation of symp-
toms suggests that the observed antibiotic prescriptions
may have been intended to treat respiratory infections.
Table 1 Multivariate analysis for factors associated with antibiotic over-prescription for diarrheal children under 5 years old without
dysentery in Asembo (N = 2685)
Factors Antibiotic
prescribed (%)
Antibiotic not
prescribed (%)
Crude odds
ratio (95% CI)
Adjustedb odds
ratio (95% CI)
Demographics
Age < 1 545/1410 (38.3%) 408 /1275 (32.0%) 1.32 (1.13–1.55)
Male 745/1410 (52.8%) 707/1275 (55.5%) 1.11 (0.95–1.29)
Recent medical history
Clinic visit within 14 days 182/1410 (12.9%) 127/1275 (10.0%) 1.34 (1.05–1.70)
Clinic visit within 14 days with
diarrheal symptom
43/1406 (3.1%) 25/1270 (2.0%) 1.57 (0.95–2.59)
Clinic visit within 14 days with
antibiotic treatment
64/1410 (4.5%) 42/1275 (3.3%) 1.40 (0.94–2.08)
Signs and symptoms
Weight-for-age < −2 263/1395 (18.9%) 254/1262 (20.1%) 0.92 (0.76–1.12)
Height-for-age < −2 369/1320 (28.0%) 324/1201 (27.0%) 1.05 (0.88–1.25)
Weight-for-height < −2 182/1302 (14.0%) 182/1181 (15.4%) 0.89 (0.71–1.11)
Measured or reported fever 1158/1410 (82.1%) 1112/1275 (87.2%) 0.67 (0.54–0.83)
Cough 691/1410 (49.0%) 601/1275 (47.1%) 1.08 (0.93–1.25)
Difficulty breathing 12/1409 (0.9%) 11/1274 (0.9%) 0.99 (0.43–2.24)
Sore throat 12/1358 (0.9%) 4/1266 (0.3%) 2.81 (0.90–8.72) 5.03 (0.73–34.91)
Vomiting 469/1410 (33.3%) 462/1272 (36.3%) 0.87 (0.75–1.03) 0.79 (0.58–1.07)
Runny nose 477/1410 (33.8%) 416/1275 (32.6%) 1.06 (0.90–1.24)
Sneezing 251/1409 (17.8%) 202/1275 (15.8%) 1.15 (0.94–1.41)
Physical examination
Restless or irritable 80/1409 (5.7%) 46/1270 (3.6%) 1.60 (1.11–2.32) 1.39 (0.81–2.40)
Sunken eyes 128/1408 (9.1%) 78/1270 (6.1%) 1.53 (1.14–2.05) 1.22 (0.80–1.84)
Drinks eagerly, thirsty 58/1407 (4.1%) 36/1268 (2.8%) 1.47 (0.96–2.25)
Skin tenting 87/1405 (6.2%) 46/1270 (3.6%) 1.76 (1.22–2.53)
Signs of anemia 30/1378 (2.2%) 36/1243 (2.9%) 0.75 (0.46–1.22)
Crackles/rales 3/1408 (0.2%) 6/1272 (0.5%) 0.45 (0.11–1.81)
Clinical diagnoses
Gastroenteritis 1292/1410 (91.6%) 792/1275 (62.1%) 6.68 (5.36–8.32) 8.23 (3.68–18.40)
Malaria 322/1410 (22.8%) 660/1275 (51.8%) 0.27 (0.23–0.33) 0.37 (0.25–0.54)
Dehydration 123/1410 (8.7%) 66/1275 (5.2%) 1.75 (1.28–2.39)
URTIa 415/1410 (29.4%) 352/1275 (27.6%) 1.09 (0.93–1.29)
Prescription
Concurrent ORSa 1130/1410 (80.1%) 830/1275 (65.1%) 2.16 (1.82–2.58) 0.49 (0.33–0.71)
Concurrent zinc 765/1410 (54.3%) 714/1275 (56.0%) 0.93 (0.80–1.09)
aURTI Upper respiratory tract infection, ORS Oral rehydration solution
bAdjusted by variables shown with adjusted OR and within-clinician variation
Odd ratio in bold indicates p-value < 0.05
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However, for this analysis we excluded clinic visits in which
patients met IMCI criteria for antibiotic treatment of pneu-
monia or very severe pneumonia, as well as visits with a
discharge diagnosis of pneumonia. Thus, any antibiotics
given for respiratory infections were likely unnecessary.
Antibiotic overuse for acute respiratory infections in
children is common [27] and must be addressed in con-
junction with overuse for diarrheal illness.
Although antibiotic over-prescription is more com-
monly recognized as a public health threat, we also iden-
tified frequent under-prescription when antibiotics were
indicated. This is especially concerning in resource-poor
Table 2 Multivariate analysis for factors associated with antibiotic over-prescription for diarrheal children under 5 years old without
dysentery in Kibera (n = 4518)
Factors Antibiotic
prescribed (%)
Antibiotic not
prescribed (%)
Crude odds
ratio (95% CI)
Adjustedb odds
ratio (95% CI)
Demographics
Age < 1 194/904 (21.5%) 938/3614 (26.0%) 0.78 (0.65–0.93) 0.82 (0.71–0.94)
Male 445/904 (49.2%) 1763/3614 (48.8%) 1.02 (0.88–1.19)
Recent medical history
Clinic visit within 14 days 111/904 (12.3%) 456/3614 (12.6%) 0.97 (0.77–1.21)
Clinic visit within 14 days with
diarrheal symptom
40/872 (4.6%) 147/3446 (4.3%) 1.08 (0.75–1.54)
Clinic visit within 14 days with
antibiotic treatment
39/904 (4.3%) 78/3614 (2.2%) 2.04 (1.38–3.02) 2.51 (1.72–3.69)
Signs and symptoms
Weight-for-age < −2 164/888 (18.5%) 625/3567 (17.5%) 1.07 (0.88–1.29)
Height-for-age < − 2 313/806 (38.8%) 1255/3010 (41.7%) 0.89 (0.76–1.04)
Weight-for-height < −2 58/792 (7.3%) 233/2989 (7.8%) 0.94 (0.69–1.26)
Measured or reported fever 188/902 (20.8%) 360/3605 (9.99%) 2.37 (1.96–2.88) 2.24 (1.56–3.23)
Cough 505/904 (55.9%) 1667/3612 (46.2%) 1.48 (1.28–1.71) 1.42 (1.06–1.90)
Difficulty breathing 8/865 (0.9%) 7/3185 (0.2%) 4.23 (1.53–11.72) 3.97 (1.28–12.30)
Sore throat 6/901 (0.7%) 24/3599 (0.7%) 1.00 (0.41–2.45)
Vomiting 98/904 (10.8%) 575/3611 (15.9%) 0.64 (0.51–0.81) 0.74 (0.53–1.03)
Runny nose 491/904 (54.3%) 1848/3612 (51.2%) 1.13 (0.98–1.31)
Sneezing 97/903 (10.7%) 480/3612 (13.3%) 0.79 (0.62–0.99) 0.74 (0.40–1.38)
Physical examination
Restless or irritable 8/903 (0.9%) 33/3585 (0.9%) 0.96 (0.44–2.09)
Sunken eyes 11/904 (1.2%) 58/3591 (1.6%) 0.75 (0.39–1.44)
Drinks eagerly, thirsty 11/904 (1.2%) 33/3598 (0.9%) 1.33 (0.67–2.64)
Skin tenting 10/904 (1.1%) 45/3592 (1.3%) 0.88 (0.44–1.76)
Signs of anemia 1/901 (0.1%) 9/3598 (0.3%) 0.44 (0.06–3.50)
Crackles/rales 32/904 (3.5%) 41/3614 (1.1%) 3.20 (2.00–5.11) 2.66 (1.34–5.30)
Clinical diagnoses
Gastroenteritis 670/904 (74.1%) 2555/3588 (71.2%) 1.16 (0.98–1.37) 1.62 (0.94–2.80)
Malaria diagnosis 15/904 (2.0%) 94/3588 (2.6%) 0.63 (0.36–1.09)
Dehydration 5/904 (0.6%) 44/3588 (1.2%) 0.45 (0.18–1.13)
URTIa 415/904 (45.9%) 1651/3588 (46.0%) 1.00 (0.86–1.15) 0.82 (0.52–1.31)
Treatment
Concurrent ORSa 578/904 (63.9%) 2420/3614 (67.0%) 0.88 (0.75–1.02) 0.81 (0.54–1.22)
Concurrent zinc 335/904 (37.1%) 1327/3614 (36.7%) 1.02 (0.87–1.18)
aURTI Upper respiratory tract infection, ORS Oral rehydration solution
bAdjusted by variables shown with adjusted OR and within-clinician variation
Odd ratio in bold indicates p-value < 0.05
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settings like Kenya where the burden of infectious dis-
eases still remains high, access to care is not always opti-
mal, and essential drugs may not readily be available. A
study evaluating the appropriateness of antibiotic use
per IMCI guidelines in Papua New Guinea reported that
11% of children in outpatient settings did not receive
antibiotics when they should have [28]. In our study,
approximately 1 in 4 dysentery cases in Asembo and 3
in 4 cases in Kibera went untreated. Shigella is a com-
mon cause of bloody diarrhea and has been previously
isolated from the stool of 36% of persons with dysentery
in Nairobi [29], and 43.9% in rural western Kenya [30].
Table 3 Multivariate analysis for factors associated with antibiotic under-prescription for diarrheal children under 5 years old with
dysentery in Western Kenya, Asembo (n = 123)
Factors Antibiotic
prescribed (%)
Antibiotic not
prescribed (%)
Crude odds
ratio (95% CI)
Adjustedb odds
ratio (95% CI)
Demographics
Age < 1 29/90 (32.2%) 12/33 (36.4%) 1.20 (0.52–2.77)
Male 50/90 (55.6%) 13/33 (39.4%) 0.52 (0.23–1.17)
Recent medical history
Clinic visit within 14 days 8/90 (8.9%) 3/33 (9.1%) 1.03 (0.26–4.12)
Clinic visit within 14 days with
diarrheal symptom
4/90 (4.4%) 1/33 (3.0%) 0.67 (0.07–6.24)
Clinic visit within 14 days with
antibiotic treatment
5/90 (5.6%) 0/33 (0%) N/A
Signs and symptoms
Weight-for-age < −2 17/89 (19.1%) 9/33 (27.3%) 1.59 (0.63–4.03)
Height-for-age < −2 22/85 (25.9%) 6/30 (20.0%) 0.72 (0.26–1.98)
Weight-for-height < −2 14/85 (16.5%) 5/30 (16.7%) 1.02 (0.33–3.10)
Measured or reported fever 81/90 (90.0%) 31/33 (93.9%) 1.72 (0.35–8.42)
Cough 54/90 (60.0%) 22/33 (66.7%) 1.33 (0.58–3.08)
Difficulty breathing 1 /90 (1.1%) 0/33 (0%) N/A
Sore throat 1/89 (0.9%) 0/32 (0%) N/A
Vomiting 23/90 (25.6%) 18/33 (54.5%) 3.50 (1.52–8.04) 4.36 (1.98–9.57)
Runny nose 27/90 (30.0%) 10/33 (30.3%) 1.02 (0.43–2.42)
Sneezing 13/90 (14.4%) 6/33 (18.2%) 1.32 (0.46–3.81)
Physical examination
Restless or irritable 7/90 (7.8%) 2/33 (6.1%) 0.77 (0.15–3.88)
Sunken eyes 8/90 (8.9%) 3/33 (12.1%) 1.41 (0.40–5.05)
Drinks eagerly, thirsty 4/90 (4.4%) 1/33 (3.0%) 0.67 (0.07–6.24)
Skin tenting 4/90 (4.4%) 0/33 (0%) N/A
Signs of anemia 4/88 (4.6%) 0/32 (0%) N/A
Crackles/rales 0/90 (0%) 0/33 (0%) N/A
Clinical diagnoses
Gastroenteritis 42/90 (45.6%) 10/33 (30.3%) 0.52 (0.22–1.22)
Malaria diagnosis 29/90 (32.2%) 18/33 (54.6%) 2.52 (1.12–5.71) 1.82 (1.05–3.13)
Dehydration 3/90 (3.3%) 3/33 (9.1%) 2.90 (0.56–15.13)
URTIa 20/90 (22.2%) 8/33 (24.2%) 1.12 (0.44–2.86)
Dysentery 47/90 (52.2%) 8/33 (24.2%) 0.29 (0.12–0.72) 0.30 (0.07–1.24)
Treatment
Concurrent ORSa 59/90 (65.6%) 14/33 (42.4%) 0.39 (0.17–0.88) 0.34 (0.10–1.19)
Concurrent zinc 41/90 (45.6%) 15/33 (45.5%) 1.00 (0.45–2.22)
aURTI Upper respiratory tract infection, ORS Oral rehydration solution
bAdjusted by variables shown with adjusted OR and within-clinician variation
Odd ratio in bold indicates p-value < 0.05
Rhee et al. BMC Public Health 2019, 19(Suppl 3):468 Page 7 of 12
Moreover, stool culture unlike molecular testing, may
underestimate the true burden of Shigella [31]. Thus,
failure to treat dysentery with antibiotics represents a
missed opportunity to reduce Shigella-related morbidity
and prevent further spread of such infections in the
community. In Kibera, a discharge diagnosis of dysentery
was negatively associated with under-prescription, sug-
gesting that clinician recognition of dysentery cases can
improve adherence to recommended management.
In Asembo, a discharge diagnosis of malaria was in-
versely associated with antibiotic over-prescription but
positively associated with antibiotic under-prescription.
Table 4 Multivariate analysis for factors associated with antibiotic under-prescription for diarrheal children under 5 years old with
dysentery in Nairobi, Kibera (n = 179)
Factors Antibiotic
prescribed (%)
Antibiotic not
prescribed (%)
Crude odds
ratio (95% CI)
Adjustedb odds
ratio (95% CI)
Demographics
Age < 1 4/47 (8.51%) 33/132 (25.0%) 3.58 (1.20–10.72) 4.76 (1.46–15.50)
Male 21/47 (44.7%) 73/132 (55.3%) 1.53 (0.78–2.99)
Recent medical history
Clinic visit within 14 days 7/47 (14.9%) 21/132 (15.9%) 1.08 (0.43–2.74)
Clinic visit within 14 days with
diarrheal symptom
3/45 (6.7%) 8/127 (6.3%) 0.94 (0.24–3.71)
Clinic visit within 14 days with
antibiotic treatment
1/47 (2.1%) 3/132 (2.3%) 1.07 (0.11–10.51)
Signs and symptoms
Weight-for-age < −2 8/47 (17.0%) 21/132 (15.9%) 0.92 (0.38–2.25)
Height-for-age < −2 23/42 (54.8%) 46/106 (43.4%) 0.63 (0.31–1.30)
Weight-for-height < − 2 3/42 (7.1%) 7/106 (6.6%) 0.92 (0.23–3.74)
Measured or reported fever 8/47 (17.0%) 13/132 (9.85%) 0.53 (0.21–1.38) 0.34 (0.11–1.05)
Cough 25/47 (53.2%) 55/132 (41.7%) 0.63 (0.32–1.22) 0.54 (0.25–1.17)
Difficulty breathing 1/43 (2.33%) 0/107 (0%) N/A
Sore throat 0/47 (0%) 0/131 (0%) N/A
Vomiting 5/47 (10.6%) 8/132 (6.1%) 0.54 (0.17–1.75)
Runny nose 27/47 (57.5%) 63/132 (47.7%) 0.68 (0.35–1.32)
Sneezing 6/47 (12.7%) 16/132 (12.1%) 0.94 (0.35–2.57)
Physical examination
Restless or irritable 0/47 (0%) 0/131 (0%) N/A
Sunken eyes 1/47 (2.1%) 0/132 (0%) N/A
Drinks eagerly, thirsty 2/47 (4.3%) 0/132 (0%) N/A
Skin tenting 1/47 (2.1%) 0/131 (0%) N/A
Signs of anemia 0/47 (0%) 1/131 (0.8%) N/A
Crackles/rales 0/47 (0%) 1/132 (0.8%) N/A
Clinical diagnoses
Gastroenteritis 32/47 (68.1%) 79/131 (60.3%) 0.71 (0.35–1.44)
Malaria diagnosis 1/47 (2.1%) 2/131 (1.5%) 0.71 (0.06–8.05)
Dehydration 1/47 (2.1%) 1/131 (0.8%) 0.35 (0.02–5.78)
URTIa 14/47 (29.8%) 40/131 (30.5%) 1.04 (0.50–2.14)
Dysentery 13/47 (27.7%) 7/131 (5.3%) 0.15 (0.06–0.40) 0.10 (0.03–0.34)
Treatment
Concurrent ORSa 37/47 (78.7%) 83/132 (62.9%) 0.46 (0.21–1.00)
Concurrent zinc 15/47 (31.9%) 42/132 (31.8%) 1.00 (0.49–2.03)
aURTI=Upper respiratory tract infection, ORS=Oral rehydration solution
bAdjusted by variables shown with adjusted OR and within-clinician variation
Odd ratio in bold indicates p-value < 0.05
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Per IMCI guidelines, a child meeting the case definition
for malaria and dysentery should be treated for both.
However, malaria diagnosis has been reported to in-
crease untargeted antibiotic use [32] and affect clinician’s
ability to detect other concurrent infections. A study of
adherence to IMCI guidelines in Tanzania reported that
health workers consistently provided recommended
therapy for a single diagnosis, but rarely diagnosed or
treated more than one condition [33]. A study in
Mozambique found a diagnosis of malaria to be leading
risk factor for failure to treat pneumonia [34]. Proper
adherence to IMCI guidelines is important for avoiding
unnecessary antibiotic use, but also to ensure that pa-
tients who should be treated with antibiotics receive
them appropriately.
Correct choice of antibiotic agent is an important
component of rational use. Although ciprofloxacin is the
recommended antibiotic for dysentery in Kenya [13], the
most commonly prescribed antibiotics for dysentery
were metronidazole, erythromycin, and nalidixic acid.
Fig. 2 Proportion and 95% confidence interval of commonly prescribed antibiotics for diarrhea with dysentery. Antibiotics are not
mutually exclusive
Fig. 3 Proportion and 95% confidence interval of commonly prescribed antibiotics for diarrhea without dysentery. Antibiotics are not
mutually exclusive
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Metronidazole and erythromycin are not effective in
treating shigellosis [17] and nalidixic acid, previously
used as the first-line antibiotic against Shigella, is no
longer recommended by the WHO, even in areas where
Shigella remains susceptible [16]. Previous studies in
Kenya have found Shigella to be susceptible to nalidixic
acid [35, 36], however ciprofloxacin has a greater activity
against Enterobacteriacae than nalidixic acid and less
chance of inducing resistance in Shigella and other
pathogens [16]. Although there are safety concerns,
especially musculoskeletal adverse events, surrounding
use of newer quinolones in pediatric patients [37], the
WHO has deemed the benefits to outweigh the risk, but
lingering concern about safety of ciprofloxacin in
children may contribute to suboptimal choice of anti-
biotic for treating pediatric dysentery [16]. Thus adher-
ence to the recommendation of ciprofloxacin for
treatment of dysentery is important for prevention of
antimicrobial resistance.
Our findings have limited generalizability as the data
are from only two private health facilities with on-going
disease surveillance and research activities. It is likely
that inappropriate antibiotic prescribing in other facil-
ities is more common than what we observed. We relied
on data documented in the medical record; inaccurate
recording of key data may have led to misclassification
of antibiotic indications and factors associated with over-
or under-prescription. Although the IMCI guideline
recommends antibiotic treatment for diarrheal illness
with a severe dehydration in the region with circulating
cholera [38], we did not consider this within our study.
Kenya has experienced outbreaks of cholera in 2007–
2010 [39], 2014 to the present [40] and these outbreaks
may have contributed to antibiotic over-prescription.
However, there were very few confirmed cholera cases
within the surveillance population during the study
period. Moreover, due to the exclusion of records with
non-diarrheal indications for antibiotics, only 1% of the
included diarrheal visits were complicated by severe de-
hydration. Thus, cholera is unlikely to have been an im-
portant consideration in assessing use of antibiotics for
childhood diarrhea. Lastly, a small number of dysentery
cases may have slightly biased estimates of odds ratio for
factors associated with antibiotic under-prescription.
Despite these limitations, our findings indicate that in-
appropriate antibiotic prescription for childhood diar-
rhea might be common in Kenya. Further assessment of
the magnitude of inappropriate antibiotic use in a
broader range of facilities and geographic locations, and
to provide more insight into the factors that shape anti-
biotic prescription for children with diarrhea. Further-
more, in Asembo, 14% of children were given antibiotics
by the caretaker before seeking care from healthcare
facilities [41], suggesting future studies should also
consider inappropriate antibiotic use before seeking
medical care. Based on our findings, antibiotic steward-
ship interventions for outpatient diarrheal case manage-
ment should address all aspects of inappropriate
antibiotic use, including over- prescription,
under-prescription and optimal choice of antibiotic
agent. Strategies might include providing routine train-
ings on appropriate antibiotic use followed by supportive
supervision and quality assurance review [42–44]. Global
efforts to improve outpatient malaria diagnostic capacity
should be continued with an emphasis on recognizing
concurrent infections, including dysentery.
Conclusions
Diarrhea is one of the most common reasons for chil-
dren to seek medical attention in Kenya and globally;
inappropriate antibiotic prescription for childhood diar-
rhea is an important and modifiable contributor to the
growing public health threat of antimicrobial resistance.
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